Cleared Traditional

CONTINUCATH 1000 INTRAVASCULAR OXYGEN MONITORING (K895150) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K895150 · Shiley, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1989
Decision
97d
Days
Class 2
Risk

K895150 is an FDA 510(k) clearance for the CONTINUCATH 1000 INTRAVASCULAR OXYGEN MONITORING. Classified as Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling (product code CCE), Class II - Special Controls.

Submitted by Shiley, Inc. (Irvine, US). The FDA issued a Cleared decision on November 28, 1989 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1200 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shiley, Inc. devices

Submission Details

510(k) Number K895150 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1989
Decision Date November 28, 1989
Days to Decision 97 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 140d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCE Analyzer, Gas, Oxygen, Partial Pressure, Blood-phase, Indwelling

Devices cleared under the same product code (CCE) and FDA review panel - the closest regulatory comparables to K895150.
TOPS NEEDLE TIP PROBE & PVC TIP PROBE
K910453 · Baxter Healthcare Corp · Aug 1991
TISSUE OXYGEN MONITOR SYSTEM, MODEL II
K890624 · Baxter Healthcare Corp · Dec 1989
NEOCATH 1000 UMBILICAL ARTERY OXYGEN MONITORING SY
K895149 · Shiley, Inc. · Nov 1989
BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR SYSTEM
K884063 · C.R. Bard, Inc. · Dec 1988
UMBILICAL ARTERY OXYGEN SENSOR
K875225 · Ohmeda Medical · Mar 1988
BARD ABG 100 INTRAVASCULAR OXYGEN MONITOR. SYSTEM
K872125 · C.R. Bard, Inc. · Dec 1987